Uncategorized
Ophthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases and Changes Name to IVERIC bio
NEW YORK--(BUSINESS WIRE)--Ophthotech announced its transition to focus on discovering and developing novel gene therapy solutions, the Company's new name is IVERIC bio, Inc.